GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » Short Percentage of Float

Advagene Biopharma Co (ROCO:6709) Short Percentage of Float


View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Advagene Biopharma Co's Short Percentage of Float

For the Biotechnology subindustry, Advagene Biopharma Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's Short Percentage of Float falls into.


Advagene Biopharma Co (ROCO:6709) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » Short Percentage of Float
Comparable Companies
ROCO:6827 ROCO:3205 ROCO:4195 ROCO:4186 ROCO:6850 ROCO:6872 ROCO:6810 ROCO:6610 ROCO:4192 ROCO:6652 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114
Website
http://www.advagene.com.tw
Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co (ROCO:6709) Headlines

No Headlines